Literature DB >> 16309624

The effect of non-enzymatic glycation on the unfolding of human serum albumin.

Deanna L Mendez1, Russell A Jensen, Laura A McElroy, Jose M Pena, Raymond M Esquerra.   

Abstract

We monitored the unfolding of human serum albumin (HSA) and glycated human serum albumin (gHSA) subjected to guanidine hydrochloride (GndHCl) by using fluorescence and circular dichroism (CD) spectroscopy. A two-state model with sloping baselines best described the Trp-214 fluorescence unfolding measurements, while a three-state model best described the far-UV CD unfolding data. Glycation of HSA increased the [D](50%) point by approximately 0.20M. This corresponded to an increase in the free energy of unfolding of gHSA relative to HSA of 2.6kJ/mol. The intrinsic fluorescence of Trp-214 in gHSA is 0.72 of that of HSA and the far-UV CD spectrum of gHSA is nearly identical to that of HSA. These results showed that glycation altered the local structure around Trp-214 while not significantly impacting the secondary structure, and this alteration translated into an overall change in the stability of gHSA compared to HSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309624     DOI: 10.1016/j.abb.2005.10.019

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  26 in total

1.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Authors:  K S Joseph; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-05-06       Impact factor: 3.935

2.  Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.

Authors:  Abby J Jackson; Jeanethe Anguizola; Erika L Pfaunmiller; David S Hage
Journal:  Anal Bioanal Chem       Date:  2013-05-09       Impact factor: 4.142

3.  Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.

Authors:  Ryan Matsuda; Zhao Li; Xiwei Zheng; David S Hage
Journal:  J Chromatogr A       Date:  2015-07-06       Impact factor: 4.759

4.  Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Donald Jobe; Jared Beyersdorf; David S Hage
Journal:  J Chromatogr A       Date:  2015-09-09       Impact factor: 4.759

5.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

6.  Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7).

Authors:  Mohd Shahnawaz Khan; Sourabh Dwivedi; Medha Priyadarshini; Shams Tabrez; Maqsood Ahmed Siddiqui; Haseeb Jagirdar; Abdulrahman M Al-Senaidy; Abdulaziz A Al-Khedhairy; Javed Musarrat
Journal:  Eur Biophys J       Date:  2013-11-12       Impact factor: 1.733

7.  D-Ribosylated Tau forms globular aggregates with high cytotoxicity.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  Cell Mol Life Sci       Date:  2009-06-11       Impact factor: 9.261

8.  Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells.

Authors:  Yan Wei; Lan Chen; Ji Chen; Lin Ge; Rong Qiao He
Journal:  BMC Cell Biol       Date:  2009-02-13       Impact factor: 4.241

9.  Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

10.  Structural mechanism of ring-opening reaction of glucose by human serum albumin.

Authors:  Yu Wang; Haiyang Yu; Xiaoli Shi; Zhipu Luo; Donghai Lin; Mingdong Huang
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.